Pastilele de slăbit Wegovy ajung în Europa. Tratamentul împotriva obezității ar putea fi distribuit și în România

Wegovy, a well-known obesity treatment, will soon be available in Europe, including a daily oral form approved by the European Commission. Eligible patients can choose between weekly injections and oral tablets containing semaglutide. The treatment is intended for adults with a BMI of at least 30 or those with a BMI between 27 and 30 with associated health conditions. Wegovy is prescription-only and requires medical evaluation to determine suitability. The oral version is expected to be available in Romania, although an official launch date has not been announced.